A phase 2 basket study of the oral MDM2 inhibitor milademetan for MDM2-amplified advanced solid tumors (MANTRA-2)

Dumbrava, EE; Chen, CT; Cote, GM; Hanna, GJ; Stinchcombe, TE; Sumrall, B; Wise-Draper, T; Kanaan, M; Duffy, S; Sumey, C; Cobb, P; Shah, N; Zhang, B; Ku, N; Doebele, RC; Gounder, M

MOLECULAR CANCER THERAPEUTICS, 2023; 22 (12):